Data availability
Not applicable.
References
Chambers CA, Dadelahi AS, Moley CR et al (2022) Nucleotide receptors mediate protection against neonatal sepsis and meningitis caused by alpha-hemolysin expressing Escherichia coli K1. FASEB J 36:1–17. https://doi.org/10.1096/fj.202101485R
Singer M, Deutschman CS, Seymour C et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc 315:801–810. https://doi.org/10.1001/jama.2016.0287
Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874. https://doi.org/10.1038/nri3552
Van Der Poll T, Van De Veerdonk FL, Scicluna BP, Netea MG (2017) The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 17:407–420. https://doi.org/10.1038/nri.2017.36
Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 395:200–211. https://doi.org/10.1016/S0140-6736(19)32989-7
Cauwels A, Rogge E, Vandendriessche B et al (2014) Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis 5:1–7. https://doi.org/10.1038/cddis.2014.70
Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310–317. https://doi.org/10.1038/nature13085
Sumi Y, Woehrle T, Chen Y et al (2014) Plasma ATP is required for neutrophil activation in a mouse sepsis model. Shock 42:142–147. https://doi.org/10.1038/jid.2014.371
Illes P, Müller CE, Jacobson KA, et al (2020) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 489–514. https://doi.org/10.1111/bph.15299
Jacobson KA, Delicado EG, Gachet C et al (2020) Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol 177:2413–2433. https://doi.org/10.1111/bph.15005
Savio LEB, de Andrade Mello P, da Silva CG, Coutinho-Silva R (2018) The P2X7 receptor in inflammatory diseases: angel or demon? Front Pharmacol 9:1–31. https://doi.org/10.3389/fphar.2018.00052
Coutinho-Silva R, Savio LEB (2021) Purinergic signalling in host innate immune defence against intracellular pathogens. Biochem Pharmacol 187:114405. https://doi.org/10.1016/j.bcp.2021.114405
Savio LEB, Coutinho-Silva R (2019) Immunomodulatory effects of P2X7 receptor in intracellular parasite infections. Curr Opin Pharmacol 47:53–58. https://doi.org/10.1016/j.coph.2019.02.005
Savio LEB, Leite-Aguiar R, Alves VS et al (2021) Purinergic signaling in the modulation of redox biology. Redox Biol 47:102137. https://doi.org/10.1016/j.redox.2021.102137
Leite-Aguiar R, Alves VS, Savio LEB, Coutinho-Silva R (2021) Targeting purinergic signaling in the dynamics of disease progression in sepsis. Front Pharmacol 11: https://doi.org/10.3389/fphar.2020.626484
Jiang LH, Mackenzie AB, North RA, Surprenant A (2000) Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors. Mol Pharmacol 58:82–88. https://doi.org/10.1124/mol.58.1.82
Jo S, Bean BP (2011) Inhibition of neuronal voltage-gated sodium channels by Brilliant Blue G. Mol Pharmacol 80:247–257. https://doi.org/10.1124/mol.110.070276
Amaral EP, Ribeiro SCM, Lanes VR, et al (2014) Pulmonary infection with hypervirulent mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog 10:. https://doi.org/10.1371/journal.ppat.1004188
Csóka B, Németh ZH, Szabó I et al (2018) Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI insight 3:1–18. https://doi.org/10.1172/jci.insight.99431
Luiz Savio B, Mello PDA, Figliuolo VR et al (2017) CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol 67:716–726. https://doi.org/10.1016/j.jhep.2017.05.021.CD39
Savio LEB, Andrade MGJ, de Andrade MP et al (2017) P2X7 Receptor signaling contributes to sepsis-associated brain dysfunction. Mol Neurobiol 54:6459–6470. https://doi.org/10.1007/s12035-016-0168-9
Larrouyet-sarto ML, Tamura AS, Alves VS, et al (2020) P2X7 receptor deletion attenuates oxidative stress and liver damage in sepsis. https://doi.org/10.1007/s11302-020-09746-7
Wu X, Ren J, Chen G et al (2017) Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption. Sci Rep 7:1–13. https://doi.org/10.1038/s41598-017-04231-5
Csóka B, Németh ZH, Töro G et al (2015) CD39 improves survival in microbial sepsis by attenuating systemic inflammation. FASEB J 29:25–36. https://doi.org/10.1096/fj.14-253567
Yang M, Lu L, Kang Z et al (2019) Overexpressed CD39 mitigates sepsis-induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3. Int J Mol Med 44:1707–1718. https://doi.org/10.3892/ijmm.2019.4349
Sueyoshi K, Ledderose C, Shen Y et al (2019) Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors. J Biol Chem 294:6283–6293. https://doi.org/10.1074/jbc.RA118.007188
Funding
This work was supported by funds from the Conselho Nacional de Desenvolvimento Cientifico e Tecnológico do Brasil – CNPq (305857/2020–7), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro – FAPERJ.
Author information
Authors and Affiliations
Contributions
L.E.B.S wrote the manuscript.
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals.
Conflict of interest
The author declares no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Savio, L.E.B. P2X receptors in the balance between inflammation and pathogen control in sepsis. Purinergic Signalling 18, 241–243 (2022). https://doi.org/10.1007/s11302-022-09870-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-022-09870-6